Cargando…
Relative value assessment: characterizing the benefit of oncology therapies through diverse survival metrics from a US perspective
OBJECTIVES: The introduction of innovative, high-cost oncology treatments, coupled with mounting budgetary pressures, necessitates value trade-offs across cancer types. Defining value is critical to informing decision-making. A cost-value analysis tool was used to assess relative clinical value from...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430994/ https://www.ncbi.nlm.nih.gov/pubmed/30936729 http://dx.doi.org/10.2147/CEOR.S177343 |